Cardiovascular News’ top 10 most popular stories of February 2022

2060

The most read stories from across Cardiovascular News in February 2022 include training for robotic procedures in the cath lab, intravascular ultrasound (IVUS) guidance for drug-eluting stent implantation, and how heart teams benefit outcomes.

  1. Expanded robotic training will benefit cardiovascular care
    Robotic systems have the potential to fundamentally change the way care is delivered to patients in the cath lab in coming decades. As the use of robotics becomes more prevalent, training the current and future generations of physicians to operate these systems is vital, Alex Mottrie and Eric Wyffels (Aalst, Belgium) argue.
  2. IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation
    The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long lesions improved long-term cardiac survival compared with angiography-guided implantation. This is according to the findings of a patient-level data meta-analysis, published in JACC: Cardiovascular Interventions.
  3. “Game changing” photon-counting CT system arrives at John Radcliffe Hospital
    The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxford, UK)—is the first in the UK to use photon-counting CT, a high resolution and dose reduction technology.
  4. Cardiovascular News 64 – February 2022
    Read the digital version of the February 2022 Cardiovascular News. In the headlines: coronary revascularisation guidelines spark debate; new data on intravascular lithotripsy (IVL) and “promising” developments on alternatives to paclitaxel for drug-coated balloons.
  5. Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn
    Researchers warned that the number of people suffering from aortic valve stenosis in the UK could place an increasing burden on the country’s capacity to treat the disease in coming years.
  6. PROACT clinical trial results published for On-X mechanical mitral valve
    Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Surgery.
  7. Heart team approach points to mortality benefit in complex cardiac patients
    Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective analysis of patients treated at a single centre in Winnipeg, Canada has concluded.
  8. On-pump and off-pump CABG confer similar outcomes over 10 years
    A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass grafting (CABG) has concluded that outcomes between the two forms of surgery are not much different.
  9. Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality
    Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospital mortality, but higher 30-day and six-month all-cause readmission than repeat surgical aortic valve replacements (SAVR) in patients with a failed aortic bioprosthetic valve.
  10. CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years
    Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session at CRT 2022 (27 February–1 March, Washington DC, USA), affirm the durability of longer-term outcomes with the ultrathin Orsiro coronary drug-eluting stent (DES) compared to Xience (Abbott).

LEAVE A REPLY

Please enter your comment!
Please enter your name here